Table 2.
Top Over Expressed Genes | ||||||
---|---|---|---|---|---|---|
Symbol | Name | LCK non-high (geometric mean of intensities) | LCK high (geometric mean of intensities) | Fold changea | Parametric p value | FDR |
CXCL9 | Chemokine (C–X–C motif) ligand 9 | 55.65 | 870.35 | 15.640 | < 1e−07 | < 1e−07 |
IGLC1 | Immunoglobulin lambda constant 1 (Mcg marker) | 186.45 | 1984.25 | 10.642 | < 1e−07 | < 1e−07 |
IGHM | Immunoglobulin heavy constant mu | 26.53 | 221 | 8.330 | < 1e−07 | < 1e−07 |
IGKC | Immunoglobulin kappa constant | 26.11 | 226.8 | 8.686 | < 1e−07 | < 1e−07 |
JCHAIN | Joining chain of multimeric IgA and IgM | 25.76 | 217.56 | 8.446 | < 1e−07 | < 1e−07 |
IGKC | Immunoglobulin kappa constant | 27.05 | 221.33 | 8.182 | < 1e−07 | < 1e−07 |
CXCL13 | Chemokine (C–X–C motif) ligand 13 | 18.99 | 151.74 | 7.991 | < 1e−07 | < 1e−07 |
IGHM | Immunoglobulin heavy constant mu | 16.18 | 113.07 | 6.988 | < 1e−07 | < 1e−07 |
TRBC1 | T cell receptor beta constant 1 | 32.03 | 208.74 | 6.517 | < 1e−07 | < 1e−07 |
IGLJ3 | Immunoglobulin lambda joining 3 | 23.3 | 154.25 | 6.620 | < 1e−07 | < 1e−07 |
IGKC | Immunoglobulin kappa constant | 103.1 | 681.32 | 6.608 | < 1e−07 | < 1e−07 |
CCL5 | Chemokine (C–C motif) ligand 5 | 27.65 | 175.54 | 6.349 | < 1e−07 | < 1e−07 |
TRBC1 | T cell receptor beta constant 1 | 31.07 | 187.03 | 6.020 | < 1e−07 | < 1e−07 |
IGLC1 | Immunoglobulin lambda constant 1 (Mcg marker) | 19.22 | 109.64 | 5.704 | < 1e−07 | < 1e−07 |
CD2 | CD2 molecule | 24.16 | 129.36 | 5.354 | < 1e−07 | < 1e−07 |
IGLJ3 | Immunoglobulin lambda joining 3 | 13.85 | 71.54 | 5.165 | < 1e−07 | < 1e−07 |
CD8A | CD8a molecule | 16.17 | 82.27 | 5.088 | < 1e−07 | < 1e−e−07 |
CD3D | CD3d molecule, delta (CD3-TCR complex) | 34.53 | 175.11 | 5.071 | < 1e−07 | < 1e−07 |
IGLV1-44 | Immunoglobulin lambda variable 1-44 | 14.17 | 72.32 | 5.104 | < 1e−07 | < 1e−07 |
GZMA | Granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) | 10.61 | 51.3 | 4.835 | < 1e−07 | < 1e−07 |
PTPRC | Protein tyrosine phosphatase, receptor type, C | 36.38 | 174.69 | 4.802 | < 1e−07 | < 1e−07 |
IGHD | Immunoglobulin heavy constant delta | 19.21 | 91.97 | 4.788 | < 1e−07 | < 1e−04 |
ADAMDEC1 | ADAM-like, decysin 1 | 27.37 | 128.21 | 4.684 | < 1e−07 | < 1e−07 |
IGLC1 | Immunoglobulin lambda constant 1 (Mcg marker) | 31.94 | 150.02 | 4.697 | < 1e−07 | < 1e−07 |
LYZ | Lysozyme | 228.58 | 1099.09 | 4.808 | < 1e−07 | < 1e−07 |
TRAC | T cell receptor alpha constant | 24.9 | 111.08 | 4.461 | < 1e−07 | < 1e−07 |
HLA-DQB1 | Major histocompatibility complex, class II, DQ beta 1 | 156.2 | 697.99 | 4.469 | < 1e−07 | < 1e−07 |
GZMB | Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 17.16 | 74.13 | 4.320 | < 1e−07 | < 1e−07 |
IGLJ3 | Immunoglobulin lambda joining 3 | 14.66 | 62.9 | 4.291 | < 1e−07 | < 1e−07 |
IDO1 | Indoleamine 2,3-dioxygenase 1 | 37.75 | 163.3 | 4.326 | < 1e−07 | < 1e−07 |
CXCL11 | Chemokine (C–X–C motif) ligand 11 | 32.26 | 139 | 4.309 | < 1e−07 | < 1e−07 |
CCL5 | Chemokine (C–C motif) ligand 5 | 49.09 | 207.14 | 4.220 | < 1e−07 | < 1e−07 |
CXCL11 | Chemokine (C–X–C motif) ligand 11 | 21.48 | 90.56 | 4.216 | < 1e−07 | < 1e−07 |
CXCL10 | Chemokine (C–X–C motif) ligand 10 | 393.84 | 1622.47 | 4.120 | 2.74E−05 | < 1e−07 |
CD52 | CD52 molecule | 50.02 | 203.76 | 4.074 | < 1e−07 | < 1e−07 |
PTPRC | Protein tyrosine phosphatase, receptor type, C | 74.72 | 304.33 | 4.073 | < 1e−07 | < 1e−07 |
HLA-DQB1 | Major histocompatibility complex, class II, DQ beta 1 | 87.61 | 351.26 | 4.009 | < 1e−07 | < 1e−07 |
Gene Ontology | ||||
---|---|---|---|---|
GO ID | GO term | Observed in selected subset | Expected in selected subset | Observed/expectedb |
Cellular component | ||||
GO:0042571 | Immunoglobulin complex, circulating | 7 | 0.15 | 46.41 |
GO:0019814 | Immunoglobulin complex | 7 | 0.22 | 32.48 |
GO:0042612 | MHC class I protein complex | 6 | 0.26 | 23.2 |
GO:0061702 | z complex | 6 | 0.3 | 19.89 |
GO:0042101 | T cell receptor complex | 6 | 0.39 | 15.47 |
Molecular function | ||||
GO:0032395 | MHC class II receptor activity | 7 | 0.17 | 41.73 |
GO:0019957 | C–C chemokine binding | 5 | 0.17 | 29.8 |
GO:0046977 | TAP binding | 6 | 0.22 | 26.82 |
GO:0019865 | Immunoglobulin binding | 6 | 0.24 | 24.76 |
GO:0004950 | Chemokine receptor activity | 8 | 0.34 | 23.84 |
GO:0001637 | G-protein coupled chemoattractant receptor activity | 8 | 0.34 | 23.84 |
GO:0023026 | MHC class II protein complex binding | 6 | 0.26 | 22.99 |
GO:0019956 | Chemokine binding | 6 | 0.28 | 21.46 |
GO:0045236 | CXCR chemokine receptor binding | 6 | 0.3 | 20.12 |
GO:0023023 | MHC protein complex binding | 6 | 0.3 | 20.12 |
Biological process | ||||
GO:0002399 | MHC class II protein complex assembly | 5 | 0.15 | 32.44 |
GO:0046113 | Nucleobase catabolic process | 5 | 0.18 | 27.8 |
GO:0002396 | MHC protein complex assembly | 5 | 0.18 | 27.8 |
GO:0010818 | T cell chemotaxis | 9 | 0.39 | 23.35 |
GO:0002480 | Antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent | 5 | 0.23 | 21.62 |
GO:0090026 | Positive regulation of monocyte chemotaxis | 7 | 0.36 | 19.46 |
GO:0010819 | Regulation of T cell chemotaxis | 5 | 0.26 | 19.46 |
GO:1901623 | Regulation of lymphocyte chemotaxis | 9 | 0.49 | 18.44 |
GO:0036037 | CD8-positive, alpha–beta T cell activation | 5 | 0.31 | 16.22 |
aFold change < 4.0 are not reported
bObserved/expected < 15.0 not reported